BTIG Reiterates Buy on Alcon, Maintains $92 Price Target

3/23/2026
Impact: 70
Healthcare

BTIG analyst Ryan Zimmerman has reiterated a Buy rating on Alcon (NYSE: ALC) and maintained a price target of $92 for the stock. This recommendation suggests confidence in Alcon's performance and potential for growth.

AI summary, not financial advice

Share: